In breast cancer cells in particular, we demonstrated that NF-κB activation was related to the expression of cyclins D1, D2, and D3, which accelerated the effects of cyclin-dependent kinase (CDK) on cell division concurrent with the phosphorylation of retinoblastoma protein. This evidence concerns the gene NFKB1 and breast carcinoma.